Exicure (XCUR) Cash from Investing Activities (2016 - 2025)

Exicure (XCUR) reported Cash from Investing Activities of $455000.0 for Q4 2025, up 321.3% quarter-over-quarter from $108000.0 in Q3 2025.

Exicure (XCUR) Cash from Investing Activities (2016 - 2025) Analysis & Trends

Exicure has reported Cash from Investing Activities for 9 years, with the latest figure at $455000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities changed N/A year-over-year to $455000.0; the trailing twelve-month figure through Mar 2026 stood at $283000.0 (up 113.54% YoY), and the FY2025 full-year result was -$1.8 million, changed N/A from the prior year.
  • Cash from Investing Activities for Q4 2025 stood at $455000.0, up from $108000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $19.2 million in Q2 2021, with the low at -$2.1 million in Q1 2025.
  • Historically, Cash from Investing Activities has averaged $3.0 million across 4 years, with a median of $711000.0 in 2023.
  • Annual changes were most pronounced in 2021 — Cash from Investing Activities jumped 443.7% — and 2023, when it slumped 226.67%.
  • Exicure's Cash from Investing Activities stood at $4.1 million in 2021, then sank by 94.96% to $207000.0 in 2022, then jumped by 243.48% to $711000.0 in 2023, then sank by 36.01% to $455000.0 in 2025.
  • The last three Cash from Investing Activities figures came in at $455000.0 (Q4 2025), $108000.0 (Q3 2025), and -$280000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -2.89 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.71 Bn 91.71 Bn - 579,519.10
10 Exicure 17.53 Mn 14.92 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 455,000.00
Dec 31, 2025 455,000.00
Sep 30, 2025 108,000.00
Sep 30, 2025 108,000.00
Jun 30, 2025 -280,000.00
Jun 30, 2025 -280,000.00
Mar 31, 2025 -2.09 Mn
Mar 31, 2025 -2.09 Mn
Dec 31, 2023 711,000.00
Dec 31, 2023 711,000.00
Jun 30, 2023 -1.90 Mn
Jun 30, 2023 -1.90 Mn
Mar 31, 2023 106,000.00
Mar 31, 2023 106,000.00
Dec 31, 2022 207,000.00
Dec 31, 2022 207,000.00
Sep 30, 2022 998,000.00
Sep 30, 2022 998,000.00
Jun 30, 2022 1.50 Mn
Jun 30, 2022 1.50 Mn